User profiles for A. B. Ong
George Ooko AbongDepartment of Food Science, Nutrition and Technology, University of Nairobi Verified email at uonbi.ac.ke Cited by 1584 |
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies
PURPOSE: To explain the variability of docetaxel pharmacokinetics through study of CYP3A
phenotype and genotype, and MDR1 genotype. PATIENTS AND METHODS: We studied …
phenotype and genotype, and MDR1 genotype. PATIENTS AND METHODS: We studied …
Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor
…, S Duncan, KC Lee, J Lim, MT Ma, AB Ong… - Antioxidants & redox …, 2015 - liebertpub.com
Aims: The NADPH oxidase (NOX) family of enzymes catalyzes the formation of reactive
oxygen species (ROS). NOX enzymes not only have a key role in a variety of physiological …
oxygen species (ROS). NOX enzymes not only have a key role in a variety of physiological …
Cognitive enhancing effects of ghrelin receptor agonists
Z Atcha, WS Chen, AB Ong, FK Wong, A Neo… - …, 2009 - Springer
Rationale Ghrelin, the endogenous ligand for the growth hormone secretagogue receptor,
has been shown to play a role in multiple physiological processes including appetite …
has been shown to play a role in multiple physiological processes including appetite …
[PDF][PDF] Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies
…, J Wong, R Lim, N Sukri, SE Lim, AB Ong… - Journal of clinical …, 2009 - researchgate.net
… Chiung-Ing Wong, Tong-San Koh, Ross Soo, Septian Hartono, Choon-Hua Thng, Evelyn
McKeegan, Wei-Peng Yong, Chien-Shing Chen, Soo-Chin Lee, John Wong, Robert Lim …
McKeegan, Wei-Peng Yong, Chien-Shing Chen, Soo-Chin Lee, John Wong, Robert Lim …
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5
…, L Fan, JY Guo, J Lamba, R Lim, HL Lim, AB Ong… - Pharmacological …, 2004 - ASPET
Gene Ontology Terms: GO: 0004497 monooxygenase activity, GO: 0005783 endoplasmic
reticulum, GO: 0005792 microsome, GO: 0006118 electron transport, GO: 0008202 steroid …
reticulum, GO: 0005792 microsome, GO: 0006118 electron transport, GO: 0008202 steroid …
A review of the contribution of cowpea leaves to food and nutrition security in East Africa
… The greatest incentive for promotion of value addition practices is successful adoption of the
products (Owade, Abong, Okoth 2018a). Increased utilization of cowpea leaves can only be …
products (Owade, Abong, Okoth 2018a). Increased utilization of cowpea leaves can only be …
A review of occurrence of glycoalkaloids in potato and potato products
There has been increasing consumption of potato products such as French fries and crisps
in most countries as a result of lifestyle change in both developed and developing countries. …
in most countries as a result of lifestyle change in both developed and developing countries. …
Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma
B Chuah, R Lim, M Boyer, AB Ong, SW Wong… - Acta …, 2007 - Taylor & Francis
Hepatocellular carcinoma (HCC) is a hypervascular tumour, which overexpresses vascular
endothelial growth factor. Thalidomide is an antiangiogenic agent with activity in refractory …
endothelial growth factor. Thalidomide is an antiangiogenic agent with activity in refractory …
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria …
…, G Aljayyoussi, TK Kwambai, BO Abong'o… - The Lancet Infectious …, 2018 - thelancet.com
Background Ivermectin is being considered for mass drug administration for malaria due to
its ability to kill mosquitoes feeding on recently treated individuals. However, standard, single …
its ability to kill mosquitoes feeding on recently treated individuals. However, standard, single …
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre …
…, P Omgba-Bassega, T Abong-Bwenda… - The lancet HIV, 2020 - thelancet.com
Background Updated WHO guidelines recommend a dolutegravir-based regimen as the
preferred first-line treatment for HIV infection and low-dose efavirenz (400 mg) as an alternative. …
preferred first-line treatment for HIV infection and low-dose efavirenz (400 mg) as an alternative. …